Clinical Trials-Primary Liver Cancer Cohort of South China-Liver Cancer

This longitudinal observational cohort study was designed to investigate factors that influencing the occurrence and long-term survival of patients with primary liver cancer. Basic informations and detailed diagnosis informations (AJCC/TNM stage, MELD score, Child-Pugh score, and BCLC stage) were collected by professional doctors. Clinical outcomes (death, recurrence, and metastasis) will be followed up every two years after therapy.Primary liver cancer (PLC) is highly malignant with high mortality which is particularly popular in China. Many factors are believed to associate with the occurrence and prognosis of liver cancer. This longitudinal observational cohort study was designed to investigate factors that influencing the occurrence and long-term survival of patients with primary liver cancer.

Study Type : Observational
Estimated Enrollment : 4000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Factors Influencing the Occurrence and Long-term Survival of Patients With Primary Liver Cancer: A Cohort Study in South China
Actual Study Start Date : January 1, 2013
Estimated Primary Completion Date : December 2025
Estimated Study Completion Date : December 2025
Contacts
Contact: Zhu Huilian, Professor +86 20 87331811 [email protected]
Contact: Fang Aiping 020-87335875 ext 504 [email protected]
Locations
China, Guangdong
Sun Yat-sen University Cancer Center Recruiting
Guangzhou, Guangdong, China, 510000

ClinicalTrials.gov Identifier: NCT03297255

Leave a Reply